Overview
Corneal endotheliitis is a rare inflammatory condition of the eye that specifically targets the corneal endothelium — the innermost single-cell layer of the cornea responsible for maintaining corneal clarity by regulating fluid balance. The disease is characterized by corneal edema (swelling), keratic precipitates (inflammatory deposits on the inner corneal surface), and mild anterior chamber inflammation. Patients typically present with blurred vision, eye redness, and discomfort, often unilaterally, though bilateral involvement can occur. The condition is frequently associated with viral infections, particularly herpes simplex virus (HSV), varicella-zoster virus (VZV), and cytomegalovirus (CMV), which are believed to trigger an immune-mediated inflammatory response against the endothelial cells. Three clinical patterns have been described: disciform, diffuse, and linear endotheliitis, each with distinct distributions of keratic precipitates and corneal edema. Disciform endotheliitis presents with a central disc-shaped area of edema, linear endotheliitis shows a progressive line of keratic precipitates, and diffuse endotheliitis involves widespread endothelial inflammation. If left untreated, chronic or recurrent episodes can lead to permanent endothelial cell loss and irreversible corneal decompensation requiring corneal transplantation. Treatment typically involves a combination of topical corticosteroids to control inflammation and antiviral therapy (such as acyclovir, valacyclovir, or ganciclovir, depending on the suspected viral etiology) to address the underlying infectious trigger. In CMV-associated cases, topical ganciclovir has shown particular efficacy. Early diagnosis and prompt treatment are essential to preserve endothelial cell density and maintain corneal transparency. Recurrences are common, and some patients may require long-term low-dose antiviral prophylaxis to prevent further episodes of inflammation and progressive endothelial cell loss.
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Corneal endotheliitis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Corneal endotheliitis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Corneal endotheliitis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Corneal endotheliitis.
Community
No community posts yet. Be the first to share your experience with Corneal endotheliitis.
Start the conversation →Latest news about Corneal endotheliitis
No recent news articles for Corneal endotheliitis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Corneal endotheliitis
What is Corneal endotheliitis?
Corneal endotheliitis is a rare inflammatory condition of the eye that specifically targets the corneal endothelium — the innermost single-cell layer of the cornea responsible for maintaining corneal clarity by regulating fluid balance. The disease is characterized by corneal edema (swelling), keratic precipitates (inflammatory deposits on the inner corneal surface), and mild anterior chamber inflammation. Patients typically present with blurred vision, eye redness, and discomfort, often unilaterally, though bilateral involvement can occur. The condition is frequently associated with viral inf
At what age does Corneal endotheliitis typically begin?
Typical onset of Corneal endotheliitis is adult. Age of onset can vary across affected individuals.